Establishment Labs Holdings Inc. (NASDAQ:ESTA – Get Free Report) has received an average recommendation of “Buy” from the six analysts that are covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $74.67.
Several equities research analysts have issued reports on the stock. Mizuho lowered their price objective on shares of Establishment Labs from $80.00 to $50.00 and set a “buy” rating for the company in a research report on Wednesday. JPMorgan Chase & Co. started coverage on shares of Establishment Labs in a research report on Thursday, August 31st. They issued an “overweight” rating and a $75.00 price objective for the company. Stephens reaffirmed an “overweight” rating and issued a $89.00 price target on shares of Establishment Labs in a research report on Friday, July 21st. Finally, B. Riley lowered their price target on shares of Establishment Labs from $95.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday.
Institutional Inflows and Outflows
Establishment Labs Stock Performance
Establishment Labs stock opened at $21.68 on Thursday. Establishment Labs has a twelve month low of $16.96 and a twelve month high of $79.88. The company has a quick ratio of 3.53, a current ratio of 3.71 and a debt-to-equity ratio of 6.08. The company’s 50-day moving average price is $41.73 and its 200-day moving average price is $57.19. The company has a market cap of $559.56 million, a PE ratio of -7.74 and a beta of 1.15.
Establishment Labs Company Profile
Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.
- Five stocks we like better than Establishment Labs
- ETF Screener: Uses and Step-by-Step Guide
- MarketBeat Week in Review – 11/6 – 11/10
- CD Calculator: Certificate of Deposit Calculator
- Data giants MongoDB and Snowflake just got upgraded
- How to Effectively Use the MarketBeat Ratings Screener
- Plug Power at tipping point; it’s make or break time for hydrogen
Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.com's FREE daily email newsletter.